DAVID SUHOCKI: Open Payments
NPI 1861483414 · WOLCOTT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$707 in 33 payments from 8 companies in 2025. Trend: 2023 $469 · 2024 $4,497 · 2025 $707
Food & beverage: $607Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $360 |
| ABBVIE INC. | 5 | $108 |
| E.R. Squibb & Sons, L.L.C. | 4 | $72 |
| UCB, Inc. | 2 | $68 |
| Lilly USA, LLC | 2 | $48 |
| GENZYME CORPORATION | 1 | $27 |
| Galderma Laboratories, L.P. | 1 | $19 |
| Organon LLC | 1 | $5 |
Products named: TREMFYA, Sotyktu, Bimzelx, RINVOQ, EBGLYSS, SKYRIZI, DUPIXENT, NEMLUVIO.
Industry payments across CT — which companies pay providers there.
